INSR and polycystic ovary syndrome: The association of insulin resistance is significantly observed with polycystic ovary syndrome, so the use of drugs that increase the sensitivity of the insulin receptor, such as metformin and β-thiazolidinedione, has been considered in the treatment of these patients.